It would be interesting to determine whether transcriptional roles of MITF could in turn contribute to the upregulation of CPEB4 at early stages of melanoma progression, particularly in the context of classical oncogenic alterations in this disease (for example, BRAF>MEK or NRAS>PI3K-dependent pathways). The gene discussed is MITF; the disease is melanoma.